Resorbable Polymer Fiber Implants with Channels for Bone Marrow Migration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implants for osteo and osteochondral defect repair lack effective communication between the bone marrow and cartilage surface, limiting tissue regeneration and nutrition delivery to deep sclerotic bone tissue.

Innovation Solution

Development of implants with channels between upper and lower surfaces, made from resorbable polymer fibers braided into a structure that allows bone marrow migration and coated with bioceramic, facilitating tissue regeneration and integration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If implants are made from solid biodegradable polymers without channels, then structural integrity is maintained, but bone marrow migration and nutrition delivery to deep tissue is prevented

Engineering Contradiction:
Improvestructural integrityVSAvoidbone marrow migration
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The implant incorporates a porous structure with interconnected channels formed from braided fiber matrices, allowing bone marrow cells and nutrients to migrate through the implant depth while maintaining structural integrity. The porosity is engineered to provide adequate mechanical support while enabling cellular infiltration and nutrition delivery to deep sclerotic bone tissue.

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The implant uses composite construction combining biodegradable polymer fibers braided into a three-dimensional matrix, creating a structure that integrates both mechanical strength and porosity. The composite architecture of interwoven fibers provides structural reliability while the inherent void spaces enable bone marrow migration.

Inventive Principle:
Principle #40Composite materials

2Ease of manufacture

If implants use random fiber distribution, then manufacturing is simplified, but tissue regeneration guidance and structural alignment are reduced

Engineering Contradiction:
Improvefiber distributionVSAvoidtissue regeneration guidance
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The implant structure is segmented into organized braided matrices with defined fiber orientations. The braiding process creates repetitive structural units with controlled fiber directions that guide tissue regeneration while maintaining manufacturing efficiency through standardized construction patterns.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the implant exhibit tailored fiber orientations and braid patterns optimized for specific functional requirements. The local structure varies to provide enhanced guidance in critical areas while maintaining overall structural integrity, with fiber orientation adapted to match underlying tissue architecture.

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP2945655B1Implants for soft and hard tissue regeneration
Publication Date: 2019.09.25 TEPHA INC
  • EP2945655B1 patent drawingFigure 1A~2
  • EP2945655B1 patent drawing

AI summary

Implants for osteo and osteochondral repair have been developed. These implants include a series of channels between the upper and lower surfaces of the implants, such that when implanted the lower surfaces are situated in an area rich in bone marrow and the channels provide a means for the bone marrow to migrate through the implant. Preferably the implants are made from resorbable polymer fibers, preferably arranged in braids that are knitted or woven together such that the braids are substantially parallel with each other. The implants may be rolled into a bundle of braids with the axis of the braids substantially parallel to the axis of the bundle, to provide channels along the axis of the bundle. A preferred embodiment includes P4HB fibers braided and knitted into a structure that is coated with a ceramic, preferably physiologic calcium phosphate.